Skip Navigation LinksHome > July 2014 - Volume 9 - Issue 7 > Prognostic Factors for Cure, Recurrence and Long-Term Surviv...
Journal of Thoracic Oncology:
doi: 10.1097/JTO.0000000000000215
Original Articles

Prognostic Factors for Cure, Recurrence and Long-Term Survival After Surgical Resection of Thymoma

Safieddine, Najib MD*; Liu, Geoffrey MD; Cuningham, Kris MD; Ming, Tsao MD; Hwang, David MD; Brade, Anthony MD§; Bezjak, Andrea MD§; Fischer, Stefan MD*; Xu, Wei PhD; Azad, Sassan BSc*; Cypel, Marcelo MD*; Darling, Gail MD*; Yasufuku, Kazu MD*; Pierre, Andrew MD*; de Perrot, Marc MD*; Waddell, Tom MD*; Keshavjee, Shaf MD*

Collapse Box


Introduction: To determine long-term outcome and risk factors for recurrence after thymectomy.

Methods: Patients who underwent thymectomy (n = 262) for a thymic tumor (1986–2010) were identified from a prospective database. Patients were classified according to World Helath Organization (WHO) histologic classification, Masaoka staging system, and completeness of resection. Risk factors for recurrence: WHO histology, tumor size, Masaoka stage and completeness of resection were analyzed.

Results: Of 262 patients, 51% were female, median age was 55 years, and 39% had myasthenia gravis. Median follow-up was 7.5 years, median tumor size was 5.4 cm, and Masaoka stage distribution was: I (25%), II (47%), III (17%), IV (4%), and (7%) not classified. Of 200 patients classified under the WHO system, there were (7%) type A, (22%) type AB, and (71%) type B; 83% had complete resection. One-hundred and sixty-nine patients received adjuvant radiotherapy, eight adjuvant chemoradiotherapy and 14 neoadjuvant chemoradiotherapy. Overall survival was 95% at 5 years, 91% at 10 years and 91% at 15 years. Recurrence occurred in 12 patients and disease-related death in four patients. Five patients underwent re-resection for recurrence with survival of 2–15 years. Only Masaoka stage and tumor size were associated with statistically significant risk of recurrence on multivariate analysis.

Conclusion: Resectable thymoma is associated with excellent prognosis. Aggressive resection of recurrent disease yielded excellent long-term results. Higher Masaoka stage is associated with a greater chance of incomplete resection. Higher Masaoka stage and increasing tumor size are independent factors associated with recurrence.

Copyright © 2014 by the European Lung Cancer Conference and the International Association for the Study of Lung Cancer.


Article Tools


Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Other Ways to Connect



Visit on your smartphone. Scan this code (QR reader app required) with your phone and be taken directly to the site.

 For additional oncology content, visit LWW Oncology Journals on Facebook.